ICER's mission is to lead innovation in comparative effectiveness research through methods that integrate considerations of clinical benefit and economic value. Through a unique collaboration with patients, clinicians, manufacturers, insurers and other healthcare stakeholders, ICER develops tools to support patient decisions and medical policy that share the goal of achieving maximum value for every healthcare dollar.
|Active Surveillance and Radical Prostatectomy for Clinically Localized, Low-Risk Prostate Cancer|
Stakeholder organizations invited to participate:
Final Appraisal Documents
Mid-Cycle Review Documents
Background Materials & Key Questions